Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01928550 · ClinicalTrials.gov registry record
Diabetes PRP and OCT
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 8
- Enrollment target
NCT01928550 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 8 participants.
The verdict
NCT01928550 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of investigational Doppler Optical Coherence Tomography (OCT) and OCT angiography in the management of proliferative diabetic retinopathy (PDR - a leading cause of blindness in diabetic patients) before and after treatment. Angiography is the mapping of the blood vessels, and Doppler detects blood flow. PDR is due to poor oxygen circulation in smaller blood vessels in the back of the eye (retina), and is observed in 80% of people who have had diabetes for more than 10 years. This study will look at how blood flow to the eye is affected before and after treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-05-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01928550
The ClinicalTrials.gov registry entry for NCT01928550 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01928550 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01928550 about?
NCT01928550 is a clinical study titled "Diabetes PRP and OCT". The purpose of this study is to evaluate the effectiveness of investigational Doppler Optical Coherence Tomography (OCT) and OCT angiography in the management of proliferative diabetic retinopathy (PDR - a leading cause of blindness in diabetic patients) before and after treatment. Angiography is th...
What is the current status of trial NCT01928550?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2013-08. Estimated completion is 2016-05-25.
Who is sponsoring clinical trial NCT01928550?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.